Restricted accessResearch articleFirst published online 2014-10
The Generation of Hybrid Electrospun Nanofiber Layer with Extracellular Matrix Derived from Human Pluripotent Stem Cells,for Regenerative Medicine Applications
Extracellular matrix (ECM) has been utilized as a biological scaffold for tissue engineering applications in a variety of body systems, due to its bioactivity and biocompatibility. In the current study we developed a modified protocol for the efficient and reproducible derivation of mesenchymal progenitor cells (MPCs) from human embryonic stem cells as well as human induced pluripotent stem cells (hiPSCs) originating from hair follicle keratinocytes (HFKTs). ECM was produced from these MPCs and characterized in comparison to adipose mesenchymal stem cell ECM, demonstrating robust ECM generation by the excised HFKT-iPSC-MPCs. Exploiting the advantages of electrospinning we generated two types of electrospun biodegradable nanofiber layers (NFLs), fabricated from polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA), which provide mechanical support for cell seeding and ECM generation. Elucidating the optimized decellularization treatment we were able to generate an available “off-the-shelf” implantable product (NFL-ECM). Using rat subcutaneous transplantation model we demonstrate that this stem-cell-derived construct is biocompatible and biodegradable and holds great potential for tissue regeneration applications.
Get full access to this article
View all access options for this article.
References
1.
BadylakS.F., FreytesD.O., and GilbertT.W.Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater, 5, 1, 2009.
2.
ChenJ., XuJ., WangA., and ZhengM.Scaffolds for tendon and ligament repair: review of the efficacy of commercial products. Expert Rev Med Devices, 6, 61, 2009.
3.
BadylakS.F.Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol, 12, 367, 2004.
4.
ReingJ.E., ZhangL., Myers-IrvinJ., CorderoK.E., FreytesD.O., Heber-KatzE., et al.Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A, 15, 605, 2009.
5.
LuH., HoshibaT., KawazoeN., KodaI., SongM., and ChenG.Cultured cell-derived extracellular matrix scaffolds for tissue engineering. Biomaterials, 32, 9658, 2011.
6.
ThakkarS., GhebesC.A., AhmedM., KelderC., van BlitterswijkC.A., SarisD., et al.Mesenchymal stromal cell-derived extracellular matrix influences gene expression of chondrocytes. Biofabrication, 5, 025003, 2013.
AltmanA.M., Abdul KhalekF.J., AltE.U., and ButlerC.E.Adipose tissue-derived stem cells enhance bioprosthetic mesh repair of ventral hernias. Plast Reconstr Surg, 126, 845, 2010.
9.
HeeschenC., LehmannR., HonoldJ., AssmusB., AicherA., WalterD.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109, 1615, 2004.
10.
RoobrouckV.D., Ulloa-MontoyaF., and VerfaillieC.M.Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res, 314, 1937, 2008.
11.
HarknessL., MahmoodA., DitzelN., AbdallahB.M., NygaardJ.V., and KassemM.Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. Bone, 48, 231, 2011.
12.
DomevH., AmitM., LaevskyI., DarA., and Itskovitz-EldorJ.Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells. Tissue Eng Part A, 18, 2290, 2012.
13.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861, 2007.
14.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., et al.Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917, 2007.
15.
LianQ., ZhangY., ZhangJ., ZhangH.K., WuX., LamF.F., et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation, 121, 1113, 2010.
16.
NovakA., ShtrichmanR., GermanguzI., SegevH., Zeevi-LevinN., FishmanB., et al.Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. Cell Reprogram, 12, 665, 2010.
17.
DongY., YongT., LiaoS., ChanC.K., StevensM.M., and RamakrishnaS.Distinctive degradation behaviors of electrospun polyglycolide, poly(DL-lactide-co-glycolide), and poly(L-lactide-co-epsilon-caprolactone) nanofibers cultured with/without porcine smooth muscle cells. Tissue Eng Part A, 16, 283, 2010.
18.
LimS.H., and MaoH.Q.Electrospun scaffolds for stem cell engineering. Adv Drug Deliv Rev, 61, 1084, 2009.
19.
Itskovitz-EldorJ., SchuldinerM., KarsentiD., EdenA., YanukaO., AmitM., et al.Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med, 6, 88, 2000.
20.
ScottM.A., NguyenV.T., LeviB., and JamesA.W.Current methods of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev, 20, 1793, 2011.
21.
TuckerH.A., and BunnellB.A.Characterization of human adipose-derived stem cells using flow cytometry. Methods Mol Biol, 702, 121, 2011.
22.
SottileV., ThomsonA., and McWhirJ.In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells, 5, 149, 2003.
23.
CohenS., LeshanskyL., ZussmanE., BurmanM., SroujiS., LivneE., et al.Repair of full-thickness tendon injury using connective tissue progenitors efficiently derived from human embryonic stem cells and fetal tissues. Tissue Eng Part A, 16, 3119, 2010.
MateizelI., De BeckerA., Van de VeldeH., De RyckeM., Van SteirteghemA., CornelissenR., et al.Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells. Reprod Biomed Online, 16, 741, 2008.
26.
KarlssonC., and LindahlA.Notch signaling in chondrogenesis. Int Rev Cell Mol Biol, 275, 65, 2009.
27.
ArpornmaeklongP., BrownS.E., WangZ., and KrebsbachP.H.Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev, 18, 955, 2009.
28.
YenM.L., HouC.H., PengK.Y., TsengP.C., JiangS.S., ShunC.T., et al. Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant, 20, 1529, 2011.
29.
LianQ., LyeE., Suan YeoK., Khia Way TanE., Salto-TellezM., LiuT.M., et al. Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells, 25, 425, 2007.
30.
BarberiT., WillisL.M., SocciN.D., and StuderL.Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med, 2, e161, 2005.
31.
LiF., BronsonS., and NiyibiziC.Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem, 109, 643, 2010.
32.
HuQ., FriedrichA.M., JohnsonL.V., and CleggD.O.Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells, 28, 1981, 2010.
33.
ChinM.H., MasonM.J., XieW., VoliniaS., SingerM., PetersonC., et al.Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5, 111, 2009.
34.
TakadaI., KouzmenkoA.P., and KatoS.PPAR-gamma signaling crosstalk in mesenchymal stem cells. PPAR Res, 2010. DOI: 10.1155/2010/341671.
35.
KleesR.F., SalasznykR.M., VandenbergS., BennettK., and PlopperG.E.Laminin-5 activates extracellular matrix production and osteogenic gene focusing in human mesenchymal stem cells. Matrix Biol, 26, 106, 2007.
36.
BadylakS.F.Regenerative medicine and developmental biology: the role of the extracellular matrix. Anat Rec B New Anat, 287, 36, 2005.
37.
HoshibaT., LuH., KawazoeN., and ChenG.Decellularized matrices for tissue engineering. Expert Opin Biol Ther, 10, 1717, 2010.
38.
LiW.J., TuliR., HuangX., LaquerriereP., and TuanR.S.Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials, 26, 5158, 2005.
39.
ThibaultR.A., Scott BaggettL., MikosA.G., and KasperF.K.Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Eng Part A, 16, 431, 2010.
40.
ShenJ., FuX., OuL., ZhangM., GuanY., WangK., et al.Construction of ureteral grafts by seeding urothelial cells and bone marrow mesenchymal stem cells into polycaprolactone-lecithin electrospun fibers. Int J Artif Organs, 33, 161, 2010.
41.
ShiveM.S., and AndersonJ.M.Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28, 5, 1997.
42.
MaZ., KotakiM., InaiR., and RamakrishnaS.Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng, 11, 101, 2005.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
